Trial
NCT03937908
Pharmacokinetics Centella Asiatica Product (CAP) in Mild Cognitive Impairment
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Oregon Health and Science University
Collaborators
National Center for Complementary and Integrative Health (NCCIH)
Condition
Cognitive Impairment
Intervention
2g Centella asiatica water extract product
Why stopped
Participant study visits not possible during COVID-19 pandemic. Funder not able to support a continuation at some future date.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-05-04